Company Analysis
Sign in

Incannex Healthcare Inc. (IXHL)

Nasdaq: IXHL · Pharmaceutical Preparations · filing with the SEC since 2021
Full chart Alerts Compare
Grade4.2
◀ Past 2.1● Present 4.5▶ Future 5.3
5 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in June.
Income statement, by fiscal year, newest first
Fiscal yearFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period endingJun 30, 2026Jun 30, 2025Jun 30, 2024Jun 30, 2023Jun 30, 2022Jun 30, 2021Jun 30, 2020
Report filedSep 25, 2026Sep 29, 2025Sep 30, 2024Oct 31, 2023Oct 28, 2022··
Revenue086,00012,000····
Research and development5,210,00010,747,00012,879,0006,309,000···
General and administrative17,817,00013,128,00017,174,0008,012,000···
Total operating expenses23,027,00023,875,00030,053,00049,668,000···
Operating income-23,027,000-23,789,000-30,041,000-49,668,000···
Interest expense0303,000·····
Interest and investment income21,00062,000206,000241,000···
Share of profit of equity-method investments-37,0000·····
Total non-operating income (expense)3,725,000-23,096,00011,612,000857,000···
Income before income taxes-19,302,000-46,885,000-18,429,000-48,811,000···
Income tax expense0030,000····
Net income-19,302,000-46,885,000-18,459,000-48,811,000···
Earnings per share, basic-1.66-40.82r-34.50b-99.60b···
Earnings per share, diluted-1.66-40.82r-34.50b-99.60b···
Weighted average shares, basic11,658,3741,148,476r538,811b512,823b···
Weighted average shares, diluted11,658,3741,148,476r538,811b512,823b···
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-30 reverse split of Feb 2026.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
us-gaap:Revenues
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest expense what its borrowing costus-gaap:InterestExpenseNonoperating
Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeInterest
Share of profit of equity-method investments its share of companies it partly ownsus-gaap:IncomeLossFromEquityMethodInvestments
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
SI Assistanton IXHL · research, not advice